ARS Pharmaceuticals
SPRY
#7272
Rank
NZ$0.99 B
Marketcap
NZ$9.99
Share price
-3.03%
Change (1 day)
-67.50%
Change (1 year)

Operating Margin for ARS Pharmaceuticals (SPRY)

Operating Margin as of July 2026 (TTM): -200.08%

According to ARS Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is -200.08%. At the end of 2025 the company had an Operating Margin of -200.26%.

Operating Margin history for ARS Pharmaceuticals from 2023 to 2026

Operating Margin at the end of each year

Year Operating Margin Change
2025-200.26%-2254.65%
20249.29%-100%
2023-225,066.67%8239.56%
2022-2,698.78%663.83%
2021-353.32%13336.09%
2020-2.63%

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.